These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 21353178

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New role for an established drug? Bisphosphonates as potential anticancer agents.
    Koul HK, Koul S, Meacham RB.
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):111-9. PubMed ID: 21876554
    [Abstract] [Full Text] [Related]

  • 3. Established role of bisphosphonate therapy for prevention of skeletal complications from myeloma bone disease.
    Terpos E, Dimopoulos MA, Berenson J.
    Crit Rev Oncol Hematol; 2011 Feb; 77 Suppl 1():S13-23. PubMed ID: 21353176
    [Abstract] [Full Text] [Related]

  • 4. Can bisphosphonates improve outcomes in patients with newly diagnosed multiple myeloma?
    Morgan GJ.
    Crit Rev Oncol Hematol; 2011 Feb; 77 Suppl 1():S24-30. PubMed ID: 21353177
    [Abstract] [Full Text] [Related]

  • 5. Zoledronic acid: a framework of emerging anticancer evidence throughout the cancer continuum.
    Terpos E.
    Crit Rev Oncol Hematol; 2011 Feb; 77 Suppl 1():S1-2. PubMed ID: 21353175
    [No Abstract] [Full Text] [Related]

  • 6. Antitumor effects of bisphosphonates.
    Green JR.
    Cancer; 2003 Feb 01; 97(3 Suppl):840-7. PubMed ID: 12548584
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
    Li YY, Chang JW, Chou WC, Liaw CC, Wang HM, Huang JS, Wang CH, Yeh KY.
    Lung Cancer; 2008 Feb 01; 59(2):180-91. PubMed ID: 17900752
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-tumour activity of zoledronic acid.
    Clézardin P.
    Cancer Treat Rev; 2005 Feb 01; 31 Suppl 3():1-8. PubMed ID: 16225995
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.
    Stresing V, Fournier PG, Bellahcène A, Benzaïd I, Mönkkönen H, Colombel M, Ebetino FH, Castronovo V, Clézardin P.
    Bone; 2011 Feb 01; 48(2):259-66. PubMed ID: 20920623
    [Abstract] [Full Text] [Related]

  • 14. Bisphosphonates as anticancer therapy for early breast cancer.
    Mahtani R, Jahanzeb M.
    Clin Breast Cancer; 2010 Oct 01; 10(5):359-66. PubMed ID: 20920980
    [Abstract] [Full Text] [Related]

  • 15. An osteoprotegerin-like peptidomimetic inhibits osteoclastic bone resorption and osteolytic bone disease in myeloma.
    Heath DJ, Vanderkerken K, Cheng X, Gallagher O, Prideaux M, Murali R, Croucher PI.
    Cancer Res; 2007 Jan 01; 67(1):202-8. PubMed ID: 17210700
    [Abstract] [Full Text] [Related]

  • 16. Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice.
    Ory B, Heymann MF, Kamijo A, Gouin F, Heymann D, Redini F.
    Cancer; 2005 Dec 01; 104(11):2522-9. PubMed ID: 16270320
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Zoledronic acid: past, present and future roles in cancer treatment.
    Saad F.
    Future Oncol; 2005 Apr 01; 1(2):149-59. PubMed ID: 16555985
    [Abstract] [Full Text] [Related]

  • 19. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
    Peng H, Sohara Y, Moats RA, Nelson MD, Groshen SG, Ye W, Reynolds CP, DeClerck YA.
    Cancer Res; 2007 Oct 01; 67(19):9346-55. PubMed ID: 17909043
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.